Management of Isolated Systolic Hypertension in Older Adults

Evidence of Clinical Benefit

Blood‑Pressure Targets

Diastolic‑Pressure Considerations

First‑Line Pharmacologic Options

Initiation and Titration Strategy

Monitoring and Safety

Escalation to Combination Therapy

Age‑Related Treatment Considerations

Lifestyle and Non‑Pharmacologic Measures

Management of Severe Isolated Systolic Hypertension

Introduction to Treatment

• The American College of Cardiology recommends immediate antihypertensive treatment for patients with severe isolated systolic hypertension, starting with a thiazide diuretic or dihydropyridine calcium channel blocker as first-line therapy, while carefully monitoring to maintain diastolic blood pressure above 70 mmHg 7

Urgency of Treatment

• The American Heart Association indicates that a systolic blood pressure of 230 mmHg represents severe hypertension requiring prompt pharmacological intervention, regardless of the normal diastolic pressure 8, 7
• Isolated systolic hypertension is the predominant form of hypertension in older adults and carries substantial risk for cardiovascular events, particularly stroke, according to the European Society of Cardiology 8, 9

First-Line Medication Selection

• The European Society of Hypertension recommends starting with either a thiazide diuretic (preferably chlorthalidone 12.5 mg daily) or a dihydropyridine calcium channel blocker (such as amlodipine 5 mg daily) as first-line therapy 7
• Chlorthalidone is preferred over hydrochlorothiazide due to its longer half-life and superior 24-hour blood pressure control, as stated by the American College of Cardiology 7

Critical Consideration: The Diastolic Dilemma

• The American Heart Association advises maintaining diastolic blood pressure ≥70 mmHg to ensure adequate coronary and renal perfusion 10
• Coronary perfusion occurs primarily during diastole, making this threshold critical especially if coronary artery disease is present, according to the European Society of Cardiology 10

Treatment Initiation Strategy

• The American College of Cardiology recommends beginning with monotherapy at the lowest recommended dose and titrating gradually 8, 10
• Initial doses should be more gradual in elderly patients due to greater risk of adverse effects, particularly orthostatic hypotension, as stated by the American Geriatrics Society 8, 9

Dose Titration and Combination Therapy

• The European Society of Hypertension suggests adding a small dose of a second drug from a different class rather than maximally increasing the first drug's dose 10
• Effective two-drug combinations include thiazide diuretic + calcium channel blocker, ACE inhibitor or ARB + calcium channel blocker, and ACE inhibitor or ARB + thiazide diuretic, according to the American Heart Association 7

Blood Pressure Targets

• The American College of Cardiology recommends an initial goal of lowering systolic blood pressure to <140 mmHg while maintaining diastolic blood pressure ≥70 mmHg 7, 10
• If well tolerated, consider targeting systolic blood pressure of 120-129 mmHg based on SPRINT trial evidence showing cardiovascular benefit from intensive treatment, as stated by the National Institutes of Health 8, 7

Essential Monitoring Parameters

• The European Society of Hypertension advises measuring blood pressure in sitting and standing positions at every visit 11, 9, 10
• Assess for symptoms of hypoperfusion: dizziness, fatigue, syncope, worsening renal function, or cardiac ischemia, according to the American Heart Association 10

Special Considerations for High-Risk Features

• The American College of Cardiology recommends considering ACE inhibitors or ARBs as first-line agents due to additional organ-protective effects in patients with established coronary artery disease, diabetes, chronic kidney disease, or elevated cardiac biomarkers 8, 7